These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26421727)

  • 1. Acute Biphasic Effects of Ayahuasca.
    Schenberg EE; Alexandre JF; Filev R; Cravo AM; Sato JR; Muthukumaraswamy SD; Yonamine M; Waguespack M; Lomnicka I; Barker SA; da Silveira DX
    PLoS One; 2015; 10(9):e0137202. PubMed ID: 26421727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Composition of Traditional and Analog Ayahuasca.
    Kaasik H; Souza RCZ; Zandonadi FS; Tófoli LF; Sussulini A
    J Psychoactive Drugs; 2021; 53(1):65-75. PubMed ID: 32896230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
    Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
    J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
    McKenna DJ
    Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an analytical method for the determination of the main ayahuasca active compounds and application to real ayahuasca samples from Brazil.
    Souza RCZ; Zandonadi FS; Freitas DP; Tófoli LFF; Sussulini A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():197-203. PubMed ID: 31220748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.
    Bouso JC; González D; Fondevila S; Cutchet M; Fernández X; Ribeiro Barbosa PC; Alcázar-Córcoles MÁ; Araújo WS; Barbanoj MJ; Fábregas JM; Riba J
    PLoS One; 2012; 7(8):e42421. PubMed ID: 22905130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The globalization of ayahuasca: harm reduction or benefit maximization?
    Tupper KW
    Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
    Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
    Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Malcolm BJ; Lee KC
    Ment Health Clin; 2017 Jan; 7(1):39-45. PubMed ID: 29955496
    [No Abstract]   [Full Text] [Related]  

  • 12. Ayahuasca, psychedelic studies and health sciences: the politics of knowledge and inquiry into an Amazonian plant brew.
    Tupper KW; Labate BC
    Curr Drug Abuse Rev; 2014; 7(2):71-80. PubMed ID: 25563448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
    Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
    Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from 'addiction'.
    Talin P; Sanabria E
    Int J Drug Policy; 2017 Jun; 44():23-30. PubMed ID: 28432902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
    Nunes AA; Dos Santos RG; Osório FL; Sanches RF; Crippa JA; Hallak JE
    J Psychoactive Drugs; 2016; 48(3):195-205. PubMed ID: 27230395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological interaction of compounds in ayahuasca: a systematic review.
    Ruffell S; Netzband N; Bird C; Young AH; Juruena MF
    Braz J Psychiatry; 2020; 42(6):646-656. PubMed ID: 32638916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ayahuasca and cancer treatment.
    Schenberg EE
    SAGE Open Med; 2013; 1():2050312113508389. PubMed ID: 26770688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.